��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
全家(5903)
月營收
季盈餘
2025/03/01
193.5元 (全家股價)
2025/03/01
1.88% (年增率)
8,702百萬元 (營收)
全家(5903) 年度營收走勢圖
全家(5903)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
8,702,462
12.81%
8,541,522
1.88%
25,283,861
1.64%
114/02
7,714,281
-13.00%
7,995,632
-3.52%
16,581,399
1.51%
114/01
8,867,118
0.76%
8,339,245
6.33%
8,867,118
6.33%
113/12
8,800,249
0.37%
8,551,990
2.90%
105,104,290
5.52%
113/11
8,767,805
-3.51%
8,314,930
5.45%
96,304,041
5.76%
113/10
9,086,954
1.21%
8,617,374
5.45%
87,536,236
5.79%
113/09
8,978,036
-2.84%
8,479,103
5.88%
78,449,282
5.83%
113/08
9,240,912
0.36%
8,893,314
3.91%
69,471,246
5.83%
113/07
9,208,139
4.68%
8,909,048
3.36%
60,230,334
6.13%
113/06
8,796,584
-0.45%
8,429,197
4.36%
51,022,195
6.64%
113/05
8,835,974
3.79%
8,361,325
5.68%
42,225,611
7.13%
113/04
8,513,238
-0.33%
7,927,683
7.39%
33,389,637
7.52%
113/03
8,541,522
6.83%
8,012,019
6.61%
24,876,399
7.57%
113/02
7,995,632
-4.12%
6,935,645
15.28%
16,334,877
8.08%
113/01
8,339,245
-2.49%
8,178,583
1.96%
8,339,245
1.96%
112/12
8,551,990
2.85%
7,821,626
9.34%
99,610,211
9.77%
112/11
8,314,930
-3.51%
7,757,919
7.18%
91,058,221
9.82%
112/10
8,617,374
1.63%
7,960,850
8.25%
82,743,291
10.09%
112/09
8,479,103
-4.66%
7,613,395
11.37%
74,125,917
10.31%
112/08
8,893,314
-0.18%
8,198,524
8.47%
65,646,814
10.17%
112/07
8,909,048
5.69%
8,200,610
8.64%
56,753,500
10.44%
112/06
8,429,197
0.81%
7,505,180
12.31%
47,844,452
10.78%
112/05
8,361,325
5.47%
7,420,441
12.68%
39,415,255
10.46%
112/04
7,927,683
-1.05%
7,268,331
9.07%
31,053,930
9.88%
112/03
8,012,019
15.52%
7,367,329
8.75%
23,126,247
10.16%
112/02
6,935,645
-15.20%
6,245,514
11.05%
15,114,228
10.92%
112/01
8,178,583
4.56%
7,380,686
10.81%
8,178,583
10.81%
111/12
7,821,626
0.82%
7,258,238
7.76%
90,740,405
8.46%
111/11
7,757,919
-2.55%
7,017,661
10.55%
82,918,779
8.53%
111/10
7,960,850
4.56%
7,378,430
7.89%
75,160,860
8.33%
111/09
7,613,395
-7.14%
6,869,297
10.83%
67,200,010
8.38%
111/08
8,198,524
-0.03%
6,968,121
17.66%
59,586,615
8.07%
111/07
8,200,610
9.27%
6,824,824
20.16%
51,388,091
6.69%
111/06
7,505,180
1.14%
6,311,274
18.92%
43,187,481
4.46%
111/05
7,420,441
2.09%
7,154,812
3.71%
35,682,301
1.86%
111/04
7,268,331
-1.34%
7,034,902
3.32%
28,261,860
1.38%
111/03
7,367,329
17.96%
7,184,987
2.54%
20,993,529
0.73%
111/02
6,245,514
-15.38%
13,626,200
111/01
7,380,686
1.69%
7,380,686
110/12
7,258,238
3.43%
83,659,512
110/11
7,017,661
-4.89%
76,401,274
110/10
7,378,430
7.41%
69,383,613
110/09
6,869,297
-1.42%
62,005,183
110/08
6,968,121
2.10%
55,135,886
110/07
6,824,824
8.14%
48,167,765
110/06
6,311,274
-11.79%
41,342,941
110/05
7,154,812
1.70%
35,031,667
110/04
7,034,902
-2.09%
27,876,855
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
